Skip to content
Noble Biomaterials logo — A global leader in antimicrobial and conductivity solutions...

Noble Biomaterials

A global leader in antimicrobial and conductivity solutions for soft surface applications. Home of Ionic+ & Circuitex.

Founded 1997 United States Scranton, United States 118 employees Grant Total: $8.03M Biotechnology, Health Care +3

General Information

Company Name Noble Biomaterials
Founded Year 1997
Location United States Scranton, United States
Employees 118
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Noble Biomaterials. To contact Noble Biomaterials, visit noblebiomaterials.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Noble Biomaterials compare?

A PDF of Noble Biomaterials and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Noble Biomaterials soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Noble Biomaterials

Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications, home of Ionic+ & Circuitex. Established in 1997, the company specializes in silver-based advanced material technologies catered to mission-critical applications in performance apparel, healthcare, industrial, and emerging wearable tech markets.

Noble's flagship brands, Ionic+ (X-STATIC, XT2) and Circuitex, are leveraged by over 250 world-class licensees to offer odor elimination, infection prevention/management, physiological monitoring, and conductive protection benefits. Notably, their technologies are integrated into products by renowned brands such as Lululemon, Giro, the US Military, NASA, 3M, and others.

With its headquarters in the United States, Noble Biomaterials received a $25.00K grant investment on 23 June 2020, with the investment coming from Ben Franklin Technology Partners of Northeastern Pennsylvania.

Noble Biomaterials operates in the biotechnology, healthcare, and manufacturing industries, emphasizing its commitment to delivering innovative solutions in these sectors.

Business keywords: antimicrobial solutions, conductivity solutions, advanced material technologies, performance apparel, healthcare industry, industrial applications, wearable tech market, odor elimination, infection prevention, physiological monitoring, conductive protection, silver-based technologies, global leader, soft surface applications, mission critical applications

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $25.00K 1
Ben Franklin Technology Partners of Northeastern Pennsylvania
23 Jun 2020
Series C Undisclosed 1
Rittenhouse Ventures
01 Jul 2013
Series B $8.00M 3
TL Ventures, DuPont Capital Management +1
10 Feb 2012

Noble Biomaterials Alternatives & Competitors

View All Alternatives
Noble Biomaterials vs

Shaping Innovation in Cardiac Surgery for over 25 years

15 employees
Health Care, Manufacturing
Noble Biomaterials vs

A Family-Enterprise Devoted to Saving Lives and Making Life Better Through Well-Being Solutions

1407 employees
Health Care, Health and Wellness
Noble Biomaterials vs

سنواصل رحلتنا لتحقيق رؤيتنا وسنكون مصدر إلهام للجميع في صناعة الأدوية.

346 employees
Biotechnology, Health Care

FAQ About Noble Biomaterials

A global leader in antimicrobial and conductivity solutions for soft surface applications. Home of Ionic+ & Circuitex.
Noble Biomaterials was founded in 1997.
Noble Biomaterials is headquartered in Scranton, United States.
Noble Biomaterials operates in Biotechnology, Health Care, Health and Wellness, Manufacturing and Sports. Its work centres on antimicrobial solutions, conductivity solutions, advanced material technologies and performance apparel.
Noble Biomaterials has approximately 118 employees.
Noble Biomaterials has completed 3 funding rounds, raising a total of $8.03M. The latest funding stage is Grant.
Top alternatives and competitors to Noble Biomaterials include Genesee Biomedical Inc, GOJO, Makers of PURELL, شركة سدير للأدوية, Macter International Limited, QuVa Pharma, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Noble Biomaterials and Genesee Biomedical Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Noble Biomaterials, https://bouncewatch.com/company/noble-biomaterials, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout